1006-1533
2014 Issue 5
..............page:1-2
The progress of inhaled corticosteroid/long-actingβ2-agonist combinations in the treatment of asthma
JIE Zhijun;,SUN Wei;
JIE Zhijun;,SUN Wei;
..............page:3-7
The progress in the application of leukotrienes modulators in the treatment of asthma
CHEN Xiaodong;,GONG Yi;
CHEN Xiaodong;,GONG Yi;
..............page:8-11,12
Research progress of anti-IgE monoclonal antibody omalizumab in the treatment of asthma
JIN Meiling;,MOU Yan;
JIN Meiling;,MOU Yan;
..............page:12-15
Application of theophylline drugs in the treatment of asthma
WENG Duanli;,ZHANG Xin;
WENG Duanli;,ZHANG Xin;
..............page:16-19
The safety of the common asthma-controlling medicines
CAI Yingyun;,LYU Qianzhou;,YE Xiaofen;
CAI Yingyun;,LYU Qianzhou;,YE Xiaofen;
..............page:20-22,23
Inhalation devices for the treatment of asthma and their usage
CHEN Ling;,CHENG Qijian;,WAN Huanying;
CHEN Ling;,CHENG Qijian;,WAN Huanying;
..............page:23-26
Clinical observation on warfarin holiday-therapy in the treatment of patients with atrial ifbrillation
GU Xiaoming;,TONG Xue;,WU Shaobo;,ZHENG Wenjing;,ZHOU Ruijun;
GU Xiaoming;,TONG Xue;,WU Shaobo;,ZHENG Wenjing;,ZHOU Ruijun;
..............page:27-28,29
..............page:29-32
cfda fa bu 10 xiang shi pin yao pin jian guan xin xi hua biao zhun
zhai zi cfda wang zhan ;
zhai zi cfda wang zhan ;
..............page:32-32
Effect of the regulation of antibiotics on the medication in the community pediatric clinic
WEI Lijun;,YOU Lan;
WEI Lijun;,YOU Lan;
..............page:33-34,35
Retrospect analysis of 163 severe cases of drug-induced liver injury
CHENG Nengneng;,WANG Xiaoyu;
CHENG Nengneng;,WANG Xiaoyu;
..............page:35-38
Study on market investigation and model of internet drug sales at home and abroad
GUO Bingjie;,GUO Zhenwu;,QU Jing;
GUO Bingjie;,GUO Zhenwu;,QU Jing;
..............page:39-41
guo jia fa gai wei gong bu 2013 nian yi yao chan ye ge xiang shu ju
zhai zi ding xiang yuan ;
zhai zi ding xiang yuan ;
..............page:41-41
Study on the pharmaceutical business model in China based on the perspective of value chain
CAO Yang;,WU Jie;
CAO Yang;,WU Jie;
..............page:42-45
Grey relational analysis on inlfuential factors of technological innovation in Chinese pharmaceutical industry
LIANG Xiaojuan;,XU Huaifu;
LIANG Xiaojuan;,XU Huaifu;
..............page:46-48,49
Determination of disodium edetate in phenylephrine hydrochloride injection by RP-HPLC
JIANG Yudan;,SHI Jianguo;
JIANG Yudan;,SHI Jianguo;
..............page:49-50,54
Synthesis of 1,2,3-triazoles and their antitumor activities in vitro
YUAN Jing;,ZHANG Chen;,ZHANG Hui;
YUAN Jing;,ZHANG Chen;,ZHANG Hui;
..............page:51-54
The development in peptide-based drugs
SUN Lichun;
SUN Lichun;
..............page:55-60
who biao zhang wo guo er tong yi gan fang kong cheng jiu
zhai zi guang ming ri bao ;
zhai zi guang ming ri bao ;
..............page:60-60
2014 nian 1 yue fda pi zhun xin yao gai kuang
zhang jian zhong ;
zhang jian zhong ;
..............page:61-61
yao pin bu liang fan ying xin xi tong bao di 59 qi guan zhu tou zuo zuo lin zhu she ji de yan zhong bu liang fan ying
zhai zi cfda wang zhan ;
zhai zi cfda wang zhan ;
..............page:62-62
..............page:63-63
pian ji wai guan jian cha ji jian jie
shang hai wei yuan ji xie you xian gong si ;
shang hai wei yuan ji xie you xian gong si ;
..............page:64-64